Volume 18 • Issue 14 July 11, 2018
Pharmadirect Logo News
   

DISCONTINUATION OF TAXOTERE® 80 MG (DOCETAXEL FOR INJECTION)

Sanofi Genzyme, a division of sanofi-aventis Canada Inc., would like to inform you that Taxotere® 80 mg (docetaxel for injection) will be discontinued. Read more

   

VOLTAREN EMULGEL – MORE OPTIONS FOR TREATING THE SOURCE OF PAIN WITHOUT A PILL

Help your patients get relief for their back and muscle or joint pain. Voltaren Emulgel brings you the same products in new, easy to identify and recommend packaging. With new names, it has never been easier to identify and recommend a formulation that targets your patients’ pain needs. Read more

   

REMINDER - BEPREVETM IS AVAILABLE FOR ORDER

Help treat the itch associated with Allergic Conjunctivitis. Read more

Info Rx
   

MYRBETRIQ®: NOW COVERED PART 1 BY MANITOBA PROVINCIAL FORMULARY WITH NO SPECIAL REQUIREMENTS

Effective July 19, 2018. Find out more here.

Info Rx
   
  

MYRBETRIQ® : MISE À JOUR DE LA COUVERTURE PAR LA RAMQ (AVEC UN CODE D’AUTORISATION SPÉCIALE)

RAMQ est la marque officielle de la Régie de l’assurance maladie du Québec. En savoir plus

   

JOY OF SIGHT PATIENT SUPPORT PROGRAM: UP TO $60 IN SAVINGS THROUGHOUT THE YEAR & MORE

PreserVision AREDS 2 Formula contains clinically proven nutrients recommended by the National Eye Institute (NEI). It comes in a smooth and easy-to-swallow soft gel - the #1 dosage form. Help your patients in their fight against AMD by directing them to the Joy of Sight Patient Support Program (joyofsight.ca): membership is free and patients receive up to $60 in savings throughout the year. Read more

   

NEW - NOW AVAILABLE TO SHIP

SootheTM Restore (Advanced Dry Eye Therapy) contains a UNIQUE combination of mineral oils, RestorylTM mineral oils. It moisturizes for FAST RELIEF, helps restore the lipid layer of tears and helps protect against tear loss. Read more

   

COLD-FX® DAILY SUPPORT - A NATURAL HEALTH PRODUCT, PROVEN BY SCIENCE

COLD-FX® Daily Support is an evidence-based product that has been assessed with more than 10 years of research, including 6 published randomized, double-blinded and placebo controlled clinical trials and 20+ published articles studying the effects of CVT-E002® in over 1600 subjects. Read more

   

DIFFERENCES BETWEEN PRODUCTS FOR ALLERGY SYMPTOM MANAGEMENT

Every season, you recognize how allergies may affect your patients’ quality of life. They may be suffering from symptoms beyond rhinitis. Patients may be experiencing ocular and sinus allergy symptoms and may benefit from an appropriate intranasal steroid (INS) product. Asking your patients a few simple questions about their most bothersome symptoms may guide you to a quick and effective recommendation. Read more

Classifieds
Classifieds